THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims. Actions the agency tookContinue Reading

WEDNESDAY, Dec. 28, 2022 (HealthDay News) — For people with heart disease, new research suggests loneliness, social isolation and living alone can shave years off your life. This trio puts people with established cardiovascular disease at greater risk of premature death, according to the international study. Cardiovascular disease refers toContinue Reading